NCT04336228View on ClinicalTrials.gov

The Role of Serotonin in Compulsive Behavior in Humans: Underlying Brain Mechanisms

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

April 1, 2020

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions
Obsessive-Compulsive Disorder/High Compulsive IndividualsHealthy Individuals
Interventions
DRUG

Escitalopram

20mg daily for 3-4 weeks.

DRUG

Placebo oral tablet

20mg placebo tablet daily for 3-4 weeks.

Trial Locations (1)

2100

Neurobiology Research Unit, Rigshospitalet, Copenhagen

All Listed Sponsors
collaborator

University of Cambridge

OTHER

collaborator

Lundbeck Foundation

OTHER

lead

Rigshospitalet, Denmark

OTHER

NCT04336228 - The Role of Serotonin in Compulsive Behavior in Humans: Underlying Brain Mechanisms | Biotech Hunter | Biotech Hunter